Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease
Journal of Pharmaceutical Analysis · 2024-04 · 14 (4) · 100910
DOI: 10.1016/j.jpha.2023.11.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-04. Verfasst von Panpan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Qilu …. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory for Natural Active Pharmaceutical Constituents Research in Universities of Shandong Province, School of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014…
- Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250014, China.
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
- Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250103, China.
Zitieren
APA
Chen, P., Zhu, Z., Geng, H., Cui, X., Han, Y., Wang, L., Zhang, Y., Lu, H., Wang, X., Zhang, Y., & Sun, C. (2024). Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease. Journal of Pharmaceutical Analysis, 14(4), 100910. https://doi.org/10.1016/j.jpha.2023.11.017
Vancouver
Chen P, Zhu Z, Geng H, Cui X, Han Y, Wang L, et al. Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease. Journal of Pharmaceutical Analysis. 2024;14(4):100910. doi:10.1016/j.jpha.2023.11.017
BibTeX
@article{Chen2024,
author = {Chen, Panpan and Zhu, Zihan and Geng, Haoyuan and Cui, Xiaoqing and Han, Yuhao and Wang, Lei and Zhang, Yaqi and Lu, Heng and Wang, Xiao and Zhang, Yun and Sun, Chenglong},
title = {Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease},
journal = {Journal of Pharmaceutical Analysis},
year = {2024},
volume = {14},
number = {4},
pages = {100910},
doi = {10.1016/j.jpha.2023.11.017}
}
EUVIMED